Sartorius has increased its 2025 target to €5 billion given robust financial results achieved in its Bioprocess Solutions (BPS) Division in 2020. Sartorius reported its Q4 2020 financials this week, revealing that total sales revenues rose to €2.3 billion ($2.8 billion) a 30% increase compared to 2019. The firm also told shareholders its order intake is up around 49% to 2.83 billion. The firm said its BPS division has experienced sharp rises in revenue and earnings, aided by its role…
Cytiva’s first acquisition since being acquired by Danaher sees it add robotic aseptic filling machines to its bioprocess offering. Vanrx Pharmasystems, and all 120 staff, will be incorporated into Cytiva, after the bioprocess vendor acquired the Canadian company for an undisclosed fee. Vanrx makes standardized aseptic filling technologies for filling vials, syringes, and cartridges, including its SA25 range of aseptic and lyophilized technologies, and the Microcell Vial Filler – a closed robotic isolator for pharmaceutical vial filling. “For now, this…